Abstract:Abstract Background Classical swine fever (CSF) is one of the most devastating pig diseases that affect the swine industry worldwide. Besides stamping out policy for eradication, immunization with vaccines of live attenuated CSF or the CSF-E2 subunit is an efficacious measure of disease control. However, after decades of efforts, it is still hard to eliminate CSF from endemically affected regions and reemerging areas. Most of previous studies demonstrated the efficacy of different CSF vaccines in laboratories under high containment conditions, which may not represent the practical performance in field farms. The inadequate vaccine efficacy induced by unrestrained factors may lead to chronic or persistent CSF infection in animals that develop a major source for virus shedding among pig populations. In this study, a vaccination-challenge-cohabitation trial on specific-pathogen-free (SPF) pigs and long-term monitoring of conventional sows and their offspring were used to evaluate the efficacy and the impact of maternally derived antibody (MDA) interference on CSF vaccines in farm applications. Results The trials demonstrated higher neutralizing antibody (NA) titers with no clinical symptoms and significant pathological changes in the CSF-E2 subunit vaccine immunized group after CSFV challenge. Additionally, none of the sentinel pigs were infected during cohabitation indicating that the CSF-E2 subunit vaccine could provoke adequately acquired immunity to prevent horizontal transmission. In field farm applications, sows immunized with CSF-E2 subunit vaccine revealed an average of higher and consistent antibody level with significant reduction of CSF viral RNA detection via saliva monitoring in contrast to those of live attenuated CSF vaccine immunized sows possessing diverse antibody titer distributions and higher viral loads. Furthermore, early application of the CSF-E2 subunit vaccine in 3-week-old piglets illustrated no MDA interference on primary immunization and could elicit consistent and long-lasting adequate antibody response suggesting the flexibility of CSF-E2 subunit vaccine on vaccination program determination. Conclusions The CSF-E2 subunit vaccine demonstrated significant efficacy and no MDA interference for immunization in both pregnant sows and piglets. These advantages provide a novel approach to avoid possible virus shedding in sow population and MDA interference in piglets for control of CSF in field farm applications.

Research Status of CSF Marker Vaccine

Marker vaccine strategies and candidate CSFV marker vaccines.

The Development of Classical Swine Fever Marker Vaccines in Recent Years

Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate

Research Progress and Challenges in Vaccine Development Against Classical Swine Fever Virus

Identification of E2 Strain with Improved Secretion and Immunogenicity Against CSFV in Piglets

Safety and DIVA Capability of Novel Live Attenuated Classical Swine Fever Marker Vaccine Candidates in Pregnant Sows

Classical Swine Fever in China-An Update Minireview

Progress on Molecular Biology and Diagnostic Technique of Classical Swine Fever Virus

Research about Different Immunization Procedures on the Immune Effect of CSFV Live Vaccine

Efficacy Evaluation of the C-strain-based Vaccines Against the Subgenotype 2.1d Classical Swine Fever Virus Emerging in China

Efficiency Comparison of a Novel E2 Subunit Vaccine and a Classic C-Strain Vaccine against Classical Swine Fever

Efficient Mucosal Vaccination of a Novel Classical Swine Fever Virus E2-Fc Fusion Protein Mediated by Neonatal Fc Receptor.

Evaluation of classical swine fever E2 (CSF-E2) subunit vaccine efficacy in the prevention of virus transmission and its potential application for virus eradication in field farms

Epidemiology, diagnosis and control of classical swine fever: Recent developments and future challenges

Recent Advances in the Diagnosis of Classical Swine Fever and Future Perspectives

Current efforts towards safe and effective live attenuated vaccines against African swine fever: challenges and prospects

Studies on the Protective Effects of Different Doses of Classical Swine Fever(csf) Vaccine Against CSF

Evaluation of a 3A-Truncated Foot-and-mouth Disease Virus in Pigs for Its Potential As a Marker Vaccine

Evaluation of classical swine fever E2 (CSF-E2) subunit vaccine efficacy in the prevention of virus transmission and impact of maternal derived antibody interference in field farm applications

Anti-Classical Swine Fever Virus Strategies